Insulet Corp.
Status: Publicly traded
Direct answer
Insulet Corp. is publicly traded on NASDAQ under the ticker PODD.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values...
Can you invest in Insulet Corp.?
Yes. Insulet Corp. trades publicly on NASDAQ as PODD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Insulet Corp.
Detailed equity research is provided by MarketSnap.